The cardiovascular market research reports by iData cover Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management and the Electrophysiology market. The fastest growing segments within interventional cardiology are expected to be driven by new technologies, such as CTO crossers, FFR guidewires and OCT catheters. The vascular access market will grow due to a combination of increasing patient population and the shift towards technologically advanced devices that will continue to gain market share at the expense of older, less expensive devices. iData’s cardiovascular device market reports also include cardiac surgery, cardiac rhythm management, and other cardiovascular devices and procedures. Check out our different cardiovascular device market reports below.
By 2020, the U.S. cardiac surgery market size was valued at $7.2 billion, with over 91,000 transcatheter heart valve replacement (TAVR) procedures performed every year. The market size is expected to increase at a growth rate of 7.7% to reach $12.1 billion in 2026. Throughout this medical market research, we analyzed 43 cardiac surgery companies
By 2020, the U.S. interventional cardiology device market size was valued at approximately $3.2 billion, with over 965,000 PCI procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.6% to reach $4.1 billion by 2026. Throughout this medical market research, we analyzed 43 interventional cardiology
By 2020, the U.S. vascular access devices market size was valued at $4.8 billion, with over 2.7 million peripherally inserted central catheter (PICC) insertion procedures performed each year. In spite of COVID19, the market size is expected to increase over the forecast period at a compound annual growth rate (CAGR) of 2.7% to reach $5.7
By 2020, the U.S. peripheral vascular device market size was valued at $7.1 billion, with over 8.26 million peripheral vascular procedures performed each year. The market size is expected to increase and reach $10.4 billion by 2026. Throughout this medical market research, we analyzed 67 peripheral vascular companies across the United States and used our comprehensive
Industry Trends Heart failure affects over five million people annually in the U.S. alone and is the costliest cardiovascular illness, with upwards of $30 billion spent on managing heart failure each year. Cardiac rhythm management devices, such as pacemakers, ICDs and CRT devices, are implanted in patients with arrhythmias to correct cardiac pacing and/or to
In 2018, the total market for cardiac rhythm management, electrophysiology and ablation devices experienced an increase over the previous year. Since these devices are critical life-saving apparatuses, the aging U.S. population means continued market growth for all market segments in this report, with particularly strong growth in the electrophysiology (EP) and ablation markets. Over the
Industry Trends A major driver of growth in the cardiac surgery market is the aging population. As the population ages, the rate of heart failure will increase. In addition, the elderly is often not suitable for open heart surgery. The aging population also drives the growth of minimally invasive procedures, such as transcatheter heart valve